The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Nasopharyngeal Neoplasms

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Nasopharyngeal Neoplasms


High impact information on Nasopharyngeal Neoplasms


Chemical compound and disease context of Nasopharyngeal Neoplasms


Biological context of Nasopharyngeal Neoplasms


Anatomical context of Nasopharyngeal Neoplasms


Gene context of Nasopharyngeal Neoplasms


Analytical, diagnostic and therapeutic context of Nasopharyngeal Neoplasms


  1. Sequence variation of latent membrane protein-1 of Epstein-Barr virus strains associated with hairy leukoplakia. Palefsky, J.M., Berline, J., Penaranda, M.E., Lennette, E.T., Greenspan, D., Greenspan, J.S. J. Infect. Dis. (1996) [Pubmed]
  2. Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma. Nazar-Stewart, V., Vaughan, T.L., Burt, R.D., Chen, C., Berwick, M., Swanson, G.M. Cancer Epidemiol. Biomarkers Prev. (1999) [Pubmed]
  3. Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II study. Fountzilas, G., Athanassiadis, A., Samantas, E., Skarlos, D., Kalogera-Fountzila, A., Nikolaou, A., Bacoyiannis, H., Stathopoulos, G., Kosmidis, P., Daniilidis, J. Semin. Oncol. (1997) [Pubmed]
  4. High activity iodine 125 endocurietherapy for recurrent skull base tumors. Kumar, P.P., Good, R.R., Leibrock, L.G., Mawk, J.R., Yonkers, A.J., Ogren, F.P. Cancer (1988) [Pubmed]
  5. Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review. Vardy, J., Wong, E., Izard, M., Clifford, A., Clarke, S.J. Anticancer Drugs (2002) [Pubmed]
  6. Formaldehyde exposure and nasopharyngeal cancer: re-examination of the National Cancer Institute Study and an update of one plant. Collins, J.J., Caporossi, J.C., Utidjian, H.M. J. Natl. Cancer Inst. (1988) [Pubmed]
  7. Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. Wolden, S.L., Zelefsky, M.J., Kraus, D.H., Rosenzweig, K.E., Chong, L.M., Shaha, A.R., Zhang, H., Harrison, L.B., Shah, J.P., Pfister, D.G. J. Clin. Oncol. (2001) [Pubmed]
  8. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. Rossi, A., Molinari, R., Boracchi, P., Del Vecchio, M., Marubini, E., Nava, M., Morandi, L., Zucali, R., Pilotti, S., Grandi, C. J. Clin. Oncol. (1988) [Pubmed]
  9. Combination bcl-2 antisense and radiation therapy for nasopharyngeal cancer. Yip, K.W., Mocanu, J.D., Au, P.Y., Sleep, G.T., Huang, D., Busson, P., Yeh, W.C., Gilbert, R., O'Sullivan, B., Gullane, P., Bastianutto, C., Liu, F.F. Clin. Cancer Res. (2005) [Pubmed]
  10. Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Cho, W.C., Yip, T.T., Yip, C., Yip, V., Thulasiraman, V., Ngan, R.K., Yip, T.T., Lau, W.H., Au, J.S., Law, S.C., Cheng, W.W., Ma, V.W., Lim, C.K. Clin. Cancer Res. (2004) [Pubmed]
  11. Case-control study evaluating the homogeneity and heterogeneity of risk factors between sinonasal and nasopharyngeal cancers. Zhu, K., Levine, R.S., Brann, E.A., Hall, H.I., Caplan, L.S., Gnepp, D.R. Int. J. Cancer (2002) [Pubmed]
  12. A Bayesian re-assessment of two Phase II trials of gemcitabine in metastatic nasopharyngeal cancer. Tan, S.B., Machin, D., Tai, B.C., Foo, K.F., Tan, E.H. Br. J. Cancer (2002) [Pubmed]
  13. Nasopharyngeal cancer: a review of 1605 patients treated radically with cobalt 60. Huang, S.C. Int. J. Radiat. Oncol. Biol. Phys. (1980) [Pubmed]
  14. Permanent iodine-125 (I-125) boost implants after external radiation therapy in nasopharyngeal cancer. Vikram, B., Mishra, S. Int. J. Radiat. Oncol. Biol. Phys. (1994) [Pubmed]
  15. Occupational exposure to chlorophenol and the risk of nasal and nasopharyngeal cancers among U.S. men aged 30 to 60. Mirabelli, M.C., Hoppin, J.A., Tolbert, P.E., Herrick, R.F., Gnepp, D.R., Brann, E.A. Am. J. Ind. Med. (2000) [Pubmed]
  16. Alteration of cellular mediated cytotoxicity, T cell receptor zeta (TcR zeta) and apoptosis related gene expression in nasopharyngeal carcinoma (NPC) patients: possible clinical relevance. Laytragoon-Lewin, N., Porwit-MacDonald, A., Mellstedt, H., Lewin, F. Anticancer Res. (2000) [Pubmed]
  17. Differential expression of metallothionein isoforms in nasopharyngeal cancer and inhibition of cell growth by antisense down-regulation of metallothionein-2A. Tan, O.J., Bay, B.H., Chow, V.T. Oncol. Rep. (2005) [Pubmed]
  18. Treatment results of 59 young patients with nasopharyngeal carcinoma. Selek, U., Ozyar, E., Ozyigit, G., Varan, A., Buyukpamukcu, M., Atahan, I.L. Int. J. Pediatr. Otorhinolaryngol. (2005) [Pubmed]
  19. Mechanism of differential sensitivity to cisplatin in nasopharyngeal carcinoma cells. Wang, X., Masters, J.R., Wong, Y.C., Lo, A.K., Tsao, S.W. Anticancer Res. (2001) [Pubmed]
  20. A cohort study of workers exposed to formaldehyde in the British chemical industry: an update. Gardner, M.J., Pannett, B., Winter, P.D., Cruddas, A.M. British journal of industrial medicine. (1993) [Pubmed]
  21. Telomerase is regulated by protein kinase C-zeta in human nasopharyngeal cancer cells. Yu, C.C., Lo, S.C., Wang, T.C. Biochem. J. (2001) [Pubmed]
  22. Overcoming of multidrug resistance by introducing the apoptosis gene, bcl-Xs, into MRP-overexpressing drug resistant cells. Ohi, Y., Kim, R., Toge, T. Int. J. Oncol. (2000) [Pubmed]
  23. Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression. Soo, R., Putti, T., Tao, Q., Goh, B.C., Lee, K.H., Kwok-Seng, L., Tan, L., Hsieh, W.S. Arch. Otolaryngol. Head Neck Surg. (2005) [Pubmed]
  24. Cdc42/Rac1 participates in the control of telomerase activity in human nasopharyngeal cancer cells. Yeh, Y.M., Pan, Y.T., Wang, T.C. Cancer Lett. (2005) [Pubmed]
  25. Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity. Kuo, M.L., Hwang, H.S., Sosnay, P.R., Kunugi, K.A., Kinsella, T.J. Cancer journal (Sudbury, Mass.) (2003) [Pubmed]
  26. Meeting report: summary of IARC monographs on formaldehyde, 2-butoxyethanol, and 1-tert-butoxy-2-propanol. Cogliano, V.J., Grosse, Y., Baan, R.A., Straif, K., Secretan, M.B., El Ghissassi, F. Environ. Health Perspect. (2005) [Pubmed]
  27. Expression of Y-Box binding protein-1 following hypericin-mediated photodynamic therapy in well-differentiated nasopharyngeal cancer in vivo. Du, H.Y., Olivo, M., Chen, Y.J., Yip, G., Tan, P.H., Matsumoto, K., Tsujimoto, M., Bay, B.H. Int. J. Mol. Med. (2005) [Pubmed]
  28. Inhibition of growth of human nasopharyngeal cancer xenografts in SCID mice by arsenic trioxide. Li, D., Du, C., Lin, Y., Wu, M. Tumori. (2002) [Pubmed]
WikiGenes - Universities